Stocks/BLDR

BLDR three-lens brief

Evidence-based stock research on BLDR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$58.13$58.97$145.68

Performance

1W
-8.1%
1M
-21.5%
3M
-24.4%
6M
-33.1%
YTD
-42.7%
1Y
-59.8%
3Y
5Y
BLDR · Nightly brief
Concern

Moved -3.94% yesterday. · Trading at 1% of its 52-week range — deep in the lower band.

  • Moved -3.94% yesterday.
  • Trading at 1% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 16.9pp over 30 days.
  • P/E of 67 — priced for high growth; little margin of safety.

BLDR closed at $58.97 (-3.94%) as of 2026-09-11. Market cap: $6.34B. P/E (trailing) 67.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $80.71 — 37% above current (21 analysts).. Concerns: moved -3.94% yesterday.; trading at 1% of its 52-week range — deep in the lower band.. Last quarter: Revenue $3.86B, net income -$3.90M, free cash flow $464.58M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BLDR, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BLDRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/BLDR"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BLDR brief"></iframe>